Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Retires Convertible Debt

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix today said that it has fully repaid its secured convertible debenture held by YA Global Investments.

The debenture had an original principal amount of $10 million and was sold to the investment firm in July 2008. The note was due in July of this year, or within four months after CombiMatrix receives payment from National Union Fire Insurance Company in accordance with a $35.7 million judgment issued by the United States District Court for the Central District of California.

In late January, CombiMatrix said that it had reached a settlement agreement with National Union, under which it will receive $25 million.

CombiMatrix said that as a result of retiring the note, it also has retired the potentially dilutive reserve of approximately 1.1 million shares of common stock that could have been issued in the conversion.

"Retiring this debt strengthens our overall financial position and better positions CombiMatrix for future growth as well as attaining our strategic objectives," CombiMatrix CFO and Treasurer Scott Burell said in a statement.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.